Kaposi's sarcoma staging: Difference between revisions
No edit summary |
|||
Line 13: | Line 13: | ||
|+ | |+ | ||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Factors}} | ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Factors}} | ||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Good Risk ( | ! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Good Risk (Subscript 0)}} | ||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Poor Risk ( | ! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Poor Risk (Subscript 1)}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | ||
Line 45: | Line 45: | ||
* Karnofsky performance status score < 70 | * Karnofsky performance status score < 70 | ||
|} | |} | ||
==References== | ==References== | ||
Revision as of 15:57, 20 January 2016
Kaposi's sarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Kaposi's sarcoma staging On the Web |
American Roentgen Ray Society Images of Kaposi's sarcoma staging |
Risk calculators and risk factors for Kaposi's sarcoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
There is no established system for the staging of Kaposi's sarcoma among immune competent patients. However, the staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, immune status, and the presence of any systemic illness.[1][2][3][4][5]
Staging
- There is no established system for the staging of Kaposi's sarcoma among immune competent patients.
- The staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, immune status, and the presence of any systemic illness.
Factors | Good Risk (Subscript 0) | Poor Risk (Subscript 1) |
---|---|---|
Tumor (T) |
|
|
Immune system (I) |
|
|
Systemic illness (S) |
|
|
References
- ↑ Kaposi Sarcoma Treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/soft-tissue-sarcoma/hp/kaposi-treatment-pdq#section/_15 Accessed on January, 20 2015
- ↑ Krown SE, Metroka C, Wernz JC (1989). "Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee". J Clin Oncol. 7 (9): 1201–7. PMID 2671281.
- ↑ Krown SE, Testa MA, Huang J (1997). "AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee". J Clin Oncol. 15 (9): 3085–92. PMID 9294471.
- ↑ Sarcoma- Kaposi Guide. Cancer.Net (2015) http://www.cancer.net/cancer-types/sarcoma-kaposi/risk-factors-and-prevention Accessed on January, 20 2015
- ↑ How is Kaposi sarcoma staged? American Cancer Association (2015) http://www.cancer.org/cancer/kaposisarcoma/detailedguide/kaposi-sarcoma-staging Accessed on January, 20 2016